Top Midday Gainers
TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.
TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.
Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.
Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.
Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.
Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.
Price: 32.95, Change: +20.64, Percent Change: +167.67